Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug authorized in Canada for addressing Attention-Deficit/Hyperactivity Disorder (ADHD) in youngsters and grown-ups . It's functions as a prodrug, meaning it’s inactive until metabolized by the body, releasing dextroamphetamine gradually over… Read More